Amicus Therapeutics Announces Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Amicus Therapeutics (FOLD) Reports In-Line Q2 EPS
August 4, 2022 7:33 AM EDTAmicus Therapeutics (NASDAQ: FOLD) reported Q2 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $85.87 million.
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
... More